Position in INBX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$123,937,829
+$39,021,098 QoQ
Shares Held
1,308,051
+3.6% QoQ
Ownership
8.89%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1
of 161 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in INBX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,717,848,806 across 523 Biotechnology names. INBX ranks #27 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in INBX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $123,937,829 | 1,308,051 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $84,916,731 | 1,263,078 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $92,250,512 | 1,167,728 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $14,915,388 | 442,856 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $396,817 | 27,808 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $516,228 | 36,900 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $611,608 | 39,715 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $3,746,495 | 239,240 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $3,342,926 | 235,916 | Shares | Defined | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||